Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

Abstract Background Anthracycline chemotherapy is an effective and widely used treatment for solid tumors and hematological malignancies regardless of its known cardiotoxicity. The mechanisms of the cardiotoxicity are not fully understood and methods to protect the heart during or following anthracy...

書目詳細資料
發表在:	Cardio-Oncology
Main Authors:	Amanda J. Favreau-Lessard, Hagen Blaszyk, Michael A. Jones, Douglas B. Sawyer, Ilka M. Pinz
格式:	Article
語言:	英语
出版:	BMC 2019-04-01
主題:	Anthracycline cardiotoxicity Doxorubicin Immune compromised mice
在線閱讀:	http://link.springer.com/article/10.1186/s40959-019-0037-6

相似書籍

Cardiotoxicity of doxorubicin – causes, prevention, prospects
由: Paweł Wesołowski, et al.
出版: (2022-11-01)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
由: Irwin K. Cheah, et al.
出版: (2023-01-01)

Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
由: Ekaterina Yu Podyacheva, et al.
出版: (2021-06-01)

Cardiac events among patients with sarcoma treated with doxorubicin by method of infusion: A real‐world database study
由: Lee D. Cranmer, et al.
出版: (2023-01-01)

Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
由: Tanawat Attachaipanich, et al.
出版: (2023-02-01)

The risk of peripartum cardiomyopathy among pediatric, adolescent, and young adult cancer patients exposed to doxorubicin: an opinion article
由: Christina Carfagnini, et al.
出版: (2024-11-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
由: D. A. Andreev, et al.
出版: (2024-09-01)

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
由: D. A. Andreev, et al.
出版: (2024-03-01)

Electrocardiographic characteristics of Nigerian children on anthracycline-based chemotherapy: A preliminary report
由: I D Peter, et al.
出版: (2017-01-01)

The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity
由: Samantha L. Gaytan, et al.
出版: (2023-03-01)

Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity
由: Fibi Meshrkey, et al.
出版: (2025-09-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
由: Parisa Firoozbakhsh, et al.
出版: (2024-05-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
由: Becky Meiners, et al.
出版: (2018-08-01)

Anthracycline-Induced Cardiotoxicity
由: Radomír Hrdina, et al.
出版: (2000-01-01)

Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
由: Hongyan Qian, et al.
出版: (2023-01-01)

Cardio- and nephroprotective effects of fractions isolated from Lycium barbarum (goji berry) in models of cardio- and nephrotoxicity in rats
由: Nadezhda Hvarchanova, et al.
出版: (2023-03-01)

microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
由: John Henderson, et al.
出版: (2021-08-01)

Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
由: Caroline J. Zeiss, et al.
出版: (2019-08-01)

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer
由: Tytti-Maria Uurasmaa, et al.
出版: (2025-01-01)

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
由: Sibren Haesen, et al.
出版: (2024-01-01)

Role of Inflammation and Redox Status on Doxorubicin-Induced Cardiotoxicity in Infant and Adult CD-1 Male Mice
由: Ana Reis-Mendes, et al.
出版: (2021-11-01)

Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability
由: Emma L. Wilkinson, et al.
出版: (2016-10-01)

Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
由: Andia Taghdiri
出版: (2024-06-01)

Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity
由: Tian-Hu Wang, et al.
出版: (2023-11-01)

Prevention and management of anthracycline induced cardiotoxicity: A review
由: Ian Osoro, et al.
出版: (2022-12-01)

Lipidomics application to explain acute cardiotoxicity induced by doxorubicin
由: Lubna Zuhair Abdul Karim, et al.
出版: (2019-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
由: Sebahat Ulusan, et al.
出版: (2023-05-01)

Cardioprotective Effect of Quercetin and Sitagliptin in Doxorubicin-Induced Cardiac Toxicity in Rats
由: Aziz TA
出版: (2021-03-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
由: Mustafa Cellat, et al.
出版: (2022-09-01)

Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know
由: Armando Ferrera, et al.
出版: (2023-05-01)

Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin-induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers
由: Adersikha Pradhan, et al.
出版: (2023-11-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
由: Rongrong Bai, et al.
出版: (2025-06-01)

Increased Dietary Leucine Reduces Doxorubicin-Associated Cardiac Dysfunction in Rats
由: Thiago M. Fidale, et al.
出版: (2018-01-01)

Survivorship clinic attendance improves completion but not timeliness of cardiac surveillance post anthracyclines
由: Zac Forbes, et al.
出版: (2025-02-01)

Role of diosmin in preventing doxorubicin-induced cardiac oxidative stress, inflammation, and hypertrophy: A mechanistic approach
由: Abdullah F. AlAsmari, et al.
出版: (2024-06-01)

The Impact of Polymorphisms in ATP-Binding Cassette Transporter Genes on Anthracycline-Induced Early Cardiotoxicity in Patients with Breast Cancer
由: Gintare Muckiene, et al.
出版: (2023-05-01)

Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?
由: Szponar Jaroslaw, et al.
出版: (2024-12-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
由: S. Slavcheva
出版: (2024-05-01)

Doxorubicin: The dogma and the bone
由: Jia Y. Wong, et al.
出版: (2016-02-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
由: Burak Dik, et al.